APLLTDAlembic Pharmaceuticals Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals · CRISIL: AA+ (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 1.7 this quarter.
Momentum from moving averages, Supertrend and RSI.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
Forensic screen of the latest filings
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹2603 Cr | ₹334 Cr | 17.76% | 12.83% | ₹17.05 | 12.5x |
| Q1 FY2027 | ₹2150 Cr | ₹172 Cr | 10.89% | 8.02% | ₹8.80 | 9.0x |
| Q4 FY2026 | ₹1848 Cr | ₹202 Cr | 7.54% | 10.91% | ₹10.31 | 6.2x |
| Q3 FY2026 | ₹1876 Cr | ₹132 Cr | 11.37% | 7.03% | ₹6.76 | 8.0x |
| Q2 FY2026 | ₹1910 Cr | ₹184 Cr | 12.54% | 9.62% | ₹9.40 | 10.2x |
| Q1 FY2026 | ₹1711 Cr | ₹154 Cr | 12.13% | 8.98% | ₹7.85 | 9.1x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.